Biowaiver studies of seven generic brands of allopurinol (100 mg) tablets available in Sudanese market

Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2017, Vol 3, Issue 11

Abstract

Abstract:Allopurinol is the drug of choice in the treatment of gout It reduces the concentration of urates and uric acid in tissues, plasma and urine, while increasing the concentration of xanthine and hypoxanthine.The purpose of this study was to examine the possibility of Biowaiver study for approval of generic brands of allopurinol tablets without additional in vivo bioequivalence and, to collect information on the safety and efficacy of the different allopurinol tablet brands using simple and cost effective in vitro methods. Physicochemical characteristics comprising drug content, hardness, friability, weight variation, disintegration and dissolution were evaluated for the six brands in comparison with the innovator. Dissolution test was carried under Biowaiver condition and the data analyzed by simple statistics and similarity and difference factors. The assay results showed that all the brands had active pharmaceutical ingredient within the specified official limits except Allo-4- , The crushing strength of three brands (Allo-1-, Allo-5- and Allo-7-) was out of the specified official limits, all the brands were complied with the specified limits For disintegration test, all the brands met the specified limits that stated by USP 32 for dissolution test , and according to f1 and f2 values, all the brands were similar to the innovator except Allo-4 and allo-6. From these results we can conclude that all the brands were met the specified limits for the physical tests, there is a failure of 9 % for content percent, and the brands were not accepted for Biowaiver under WHO criteria. Keywords:Biowaiver, Allopurinol, Dissolution, Bioequivalence studies

Authors and Affiliations

Raja Y. Alghadi, Elnazeer I. Hamedelniel

Keywords

Related Articles

Retro-Lunar Dislocations: About 12 Cases

The retro-lunar carpal dislocations are often under-diagnosed in the emergency services by the lack of knowledge of the pathology. The modalities of taking care of the lunations are still discussed; if the surgical treat...

Oral Colonization of Aerobic Gram Positive and Gram Negative Bacteria in Individuals Irradiated For Head and Neck Malignancies

Abstract:The oropharyngeal aerobic gram-negative bacillary carriage, uncommon in healthy people, is high in patients with head and neck cancer. A marked increase in oral Gram-negative enterobacteria and pseudomonads has...

Contemporary Review of Cardiac Amyloidosis

Abstract: Cardiac amyloidosis is underdiagnosed. Prevalence is increasing with age. Diagnosis can be elusive and challenging. High index of suspicion is required for recognition and prompt diagnosis. Cardiac amyloid diag...

Prevalence and Pattern of Thyroid Dysfunction among the Women of Rupandehi District of Nepal

Abstract:Thyroid dysfunction is one of the most common endocrine disorder and its outcomes are social, psychological and medical burden to the world. This study is designed to determine the prevalence and pattern of thyr...

Carcinomatous Meningitis from Solid Tumors: A Seven Years’ Experience in Moroccan Patients

Abstract:Carcinomatous meningitis from solid tumors has not been investigated in detail in the Moroccan population. Therefore, we reviewed our experience with this disease to determine its clinical features and treatment...

Download PDF file
  • EP ID EP393610
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Raja Y. Alghadi, Elnazeer I. Hamedelniel (2017). Biowaiver studies of seven generic brands of allopurinol (100 mg) tablets available in Sudanese market. Saudi Journal of Medical and Pharmaceutical Sciences, 3(11), 1230-1236. https://europub.co.uk/articles/-A-393610